IND approval gives celiac patients possibility to eat gluten 29-Aug-2019 By Maggie Lynch The FDA approves an IND application from ActoBio for AG017, an oral biologic drug candidate for the reversal of celiac disease, a condition which currently has no approved treatments.
NIH signs on IDT Biologika to manufacture clinical trial supply 16-Jul-2019 By Maggie Lynch The NIH has contracted IDT Biologika to manufacture five E. coli master cell banks for BLA, IND, and Phase I/II trial supply.
